T-group (topology)
2011.2.1 Peptidyl-tRNA hydrolase-like
Ligands and drugs
3,768
Member domains
1,588
with ligand contacts (≤ 4 Å)
42.1% of members
1,519
with DrugDomain annotations
40.3% of members
1,383
with a DrugBank compound
36.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2011.2.1 belongs to X-group 2011 Phosphorylase/hydrolase-like, which binds 8.3 ligand superclasses per 20 proteins, broader than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00173 | ADE | Adenine | 87 |
| DB03419 | URA | Uracil | 77 |
| DB03101 | R1P | Ribose-1-Phosphate | 46 |
| DB02281 | FMC | Formycin | 44 |
| DB04485 | THM | Thymidine | 44 |
| DB04076 | HPA | Hypoxanthine | 41 |
| DB02256 | DUR | 2'-Deoxyuridine | 36 |
| DB02282 | MTA | 5'-S-methyl-5'-thioadenosine | 35 |
| DB03551 | DIH | (3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium | 35 |
| DB00640 | ADN | Adenosine | 34 |
| DB00544 | URF | Fluorouracil | 32 |
| DB02681 | V7O | 2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium | 30 |
| DB02745 | URI | Uridine | 27 |
| DB06185 | IMH | Forodesine | 26 |
| DB03462 | TDR | Thymine | 22 |
| DB04627 | ANU | Cyclouridine | 22 |
| DB02377 | GUN | Guanine | 18 |
| DB07437 | BAU | 5-Benzylacyclouridine | 17 |
| DB02857 | GMP | Guanosine | 16 |
| DB03172 | TBN | Tubercidin | 14 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| Kmetal | POTASSIUM ION | 144 |
| CL | CHLORIDE ION | 128 |
| NAmetal | SODIUM ION | 120 |
| ADE | ADENINE | 94 |
| URA | URACIL | 76 |
| MGmetal | MAGNESIUM ION | 61 |
| MTA | 5'-DEOXY-5'-METHYLTHIOADENOSINE | 47 |
| R1P | 1-O-phosphono-alpha-D-ribofuranose | 45 |
| FMC | (1S)-1-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-D-ribitol | 44 |
| THM | THYMIDINE | 44 |
| IM5 | 2-amino-7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | 42 |
| HPA | HYPOXANTHINE | 40 |
| ADN | ADENOSINE | 39 |
| DUR | 2'-DEOXYURIDINE | 36 |
| DIH | 7-[[(3R,4R)-3-(hydroxymethyl)-4-oxidanyl-pyrrolidin-1-ium-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 35 |
| URF | 5-FLUOROURACIL | 32 |
| V7O | META VANADATE | 30 |
| URI | URIDINE | 27 |
| IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN-9-YL)-D-RIBITOL | 26 |
| ANU | 2,2'-Anhydro-(1-beta-D-arabinofuranosyl)uracil | 22 |